AMGEN Message Board - Msg: 52764

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMGEN

AMGN 296.30

-0.7%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nathan L. who wrote (7)	4/12/1996 9:34:00 AM
From: olduser	of 42

I don't know about earning date but there are news items of interest. One released during the last week of March stated that the sales and earning from the lead products (epogen and neupogen) will grow at a slower rate than expacted. Second news item has to do about the protein leptin (fat gene). It seems that interneuron inc had filed for a patent for the receptor for this protein and may have a lead of 12-18 months over amgn. I have to check the details but these two items may have a negative impact on the stock and thats why it has been going down. good luck Davy Kalonia

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next